Nuclear factor-κB (NF-κB) is a key regulator of systematic inflammation in atherosclerosis (AS). The mammalian target of rapamycin (mTOR), a serine/threonine protein kinase, has emerged as an important regulator of chronic inflammation. However, the relationship between mTOR and NF-κB remains poorly defined. The aim of the present study was to investigate the role of mTOR in the pro-inflammatory pathway of human monocytes (HMCs) in patients with coronary artery disease (CAD) and to determine the interaction between mTOR and NF-κB signalling in the inflammatory state. HMCs were isolated from fasting blood samples of 68 patients with CAD and 59 subjects without CAD (non-CAD) to test the activity of NF-κB, p65 nuclear translocation and mTOR phosphorylation, which were all significantly elevated in the CAD group compared with those in the non-CAD group. The concentrations of serum interleukin (IL)-6 and tumour necrosis factor (TNF)-α were higher in the CAD group than in the non-CAD group. In an in vitro experiment, HMCs isolated from non-CAD subjects were used as culture model and were treated with sera extracted from CAD patients (CAD sera) or non-CAD subjects (con sera). CAD sera induced time-dependent phosphorylation of mTOR, aberrant NF-κB activation, as well as up-regulation of inflammatory factors. Moreover, inhibition of mTOR by pharmacological or genetic means abolished the CAD sera-triggered NF-κB activation and pro-inflammatory response. Furthermore, lipid-lowering drug statins partly blocked the CAD sera-activated mTOR and pro-inflammatory response. Our results show that CAD patients are in the pro-inflammatory state with increased NF-κB binding activity and enhanced mTOR phosphorylation. We also found that the activation of mTOR is required for the pro-inflammatory response via NF-κB-dependent pathway in HMCs, which unveils the underlying mechanism of AS and potential strategies to attenuate AS in clinical practice.
Skip Nav Destination
Article navigation
Research Article|
January 23 2015
The activation of mTOR is required for monocyte pro-inflammatory response in patients with coronary artery disease
Shanshan Gao;
Shanshan Gao
1
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Search for other works by this author on:
Weimin Liu;
Weimin Liu
1
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Search for other works by this author on:
Xiaozhen Zhuo;
Xiaozhen Zhuo
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Search for other works by this author on:
Lijun Wang;
Lijun Wang
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Search for other works by this author on:
Gang Wang;
Gang Wang
†Department of Cardiology, Second Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710004, China
Search for other works by this author on:
Tao Sun;
Tao Sun
‡Department of Pharmaceutics, Tangdu Hospital, Fourth Military Medical University, Shaanxi Xi’an 710038, China
Search for other works by this author on:
Zhao Zhao;
Zhao Zhao
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Search for other works by this author on:
Junhui Liu;
Junhui Liu
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Search for other works by this author on:
Yuling Tian;
Yuling Tian
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Search for other works by this author on:
Juan Zhou;
Juan Zhou
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Search for other works by this author on:
Zuyi Yuan;
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Correspondence: Dr Yue Wu (email [email protected]) or Prof Zuyi Yuan (email [email protected]).
Search for other works by this author on:
Yue Wu
*Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi Xi’an 710061, China
Correspondence: Dr Yue Wu (email [email protected]) or Prof Zuyi Yuan (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
July 11 2014
Revision Received:
October 23 2014
Accepted:
November 27 2014
Accepted Manuscript online:
November 27 2014
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2015 Biochemical Society
2015
Clin Sci (Lond) (2015) 128 (8): 517–526.
Article history
Received:
July 11 2014
Revision Received:
October 23 2014
Accepted:
November 27 2014
Accepted Manuscript online:
November 27 2014
Citation
Shanshan Gao, Weimin Liu, Xiaozhen Zhuo, Lijun Wang, Gang Wang, Tao Sun, Zhao Zhao, Junhui Liu, Yuling Tian, Juan Zhou, Zuyi Yuan, Yue Wu; The activation of mTOR is required for monocyte pro-inflammatory response in patients with coronary artery disease. Clin Sci (Lond) 1 April 2015; 128 (8): 517–526. doi: https://doi.org/10.1042/CS20140427
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |